Exhibitors
Prestige Biopharma
Profile
Prestige BioPharma is a Singapore-based biopharmaceutical company focusing on the development of biosimilars and new antibody therapeutics. Its lead program, HD201 trastuzumab biosimilar, has been filed with EMA in April 2019 and will also be filed with USFDA in 2019. Prestige BioPharma’s next products in line include a Bevacizumab biosimilar.